S5/10Economic
Tariff-Proof But Not China-Proof: The Geopolitics of India’s Pharma Power
Washington has spared India’s generics from its new drug tariffs. But the real exposure running through India’s pharmacy lies upstream, in China – and it is the West’s problem too.
Click a tag to subscribe via email/Telegram (manage channels in Account).
⚠️ This is a probabilistic forecast, not a guarantee. Accuracy is measured only on resolved scenarios; monitor confirmation indicators below.
A
Эскалация— 24% model probability
Forecast derived from cascade analysis. Watch confirmation indicators below.
Horizon: 7–30 days